| Place of Origin: | China |
|---|---|
| Brand Name: | Senwayer Brand |
| Certification: | ISO, 9001, USP |
| Model Number: | 6809-52-5 |
| Minimum Order Quantity: | 10grams |
| Price: | Discount is possible if your order is big enough |
| Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
| Delivery Time: | within 2 working days |
| Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
| Supply Ability: | 1000kg/month |
| CAS: | 6809-52-5 | MF: | C24H40O |
|---|---|---|---|
| Apparence: | Yellow Liquid | Purity: | 99% |
| Other Name: | Teprenone, Selbex;Tetraprenylacetone;Teprenone | Stock: | Available |
| High Light: | anti inflammatory medications,anti histaminic drugs |
||
Medical Effective Anti-ulcerative Raw Drugs Teprenone CAS 6809-52-5 Yellow Liquid
Quick detail
| Teprenone | |
| CAS No.: | 6809-52-5 |
| Synonyms: | 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one;TEPRENONE;13,17-nonadecatetraen-2-one,6,10,14,18-tetramethyl-9;geranylgeranylacetone;6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetren-2 one;Selbex;Tetraprenylacetone;Teprenone(mixture of isomers) |
| Formula: | C24H40O |
| Exact Mass: | 344.30800 |
| Molecular Weight: | 344.57400 |
| PSA: | 17.07000 |
| LogP: | 7.89140 |
| Properties | |
| Density: | 0.872g/cm3 |
| Boiling Point: | 442.2ºC at 760 mmHg |
| Flash Point: | 168ºC |
| Refractive Index: | 1.483 |
Teprenone Description
Teprenone (or geranylgeranylacetone) is a pharmaceutical drug used for the treatment of gastric ulcers.
Teprenone Usage
| Usage 1 | Usage An anti-ulcerative. |
| Usage 2 | Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spinal and bulbar muscular atrophy (cytoprotective and anti-inflammatory effects). |
| Usage 3 |
Reports indicate that GGA protects against NSAID-induced gastric and intestinal lesions by induction of HSP70 expression.
|
| Usage 4 | Other studies have shown that GGA induces expression of HSPB8 and HSPB1 and reduces the formation of amyloid oligomers as well as insoluble aggregates in HSPB5 R120G TG mice. |
